Perakizumab, a emerging drug the developers, represents a significant step in the management against various scarring conditions. Unlike existing therapies, this molecule specifically targets and inhibits the beta-TGF https://isaiahzbyy267988.aboutyoublog.com/52739917/perakizumab-a-promising-treatment-for-fibrosis-conditions